Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Texas Health Center COVID-19 Survey Summary Report

Texas Health Center COVID-19 Survey Summary Report

Latest data from November 4, 2022

Number of Health Center respondents = 57 (79% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 11,835
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 85.00%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 429
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 79.84%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 13.98% 18.18%
White, Hispanic/Latino Patients 62.21% 58.97%
Black/African American, Non-Hispanic/Latino Patients 7.78% 6.06%
Black/African American, Hispanic/Latino Patients 0.74% 0.93%
Asian Patients3 1.37% 1.17%
American Indian/Alaska Native Patients3 0.43% 0.47%
Native Hawaiian/Other Pacific Islander Patients3 0.20% 0.00%
Patients with More Than One Race3 2.15% 0.70%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.30% 3.73%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.79% 0.93%
Unreported/Refused to Report Race and Ethnicity 6.03% 8.86%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,040
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 87.51%
COVID-19 Immunization Series Completed 565
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 87.13%
COVID-19 Immunization Series Additional 2,923
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 83.90%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 11.83% 12.21% 15.33%
White, Hispanic/Latino Patients 65.29% 62.30% 59.87%
Black/African American, Non-Hispanic/Latino Patients 6.44% 5.84% 7.53%
Black/African American, Hispanic/Latino Patients 0.67% 1.95% 0.24%
Asian Patients3 2.21% 1.59% 1.27%
American Indian/Alaska Native Patients3 0.58% 0.18% 0.75%
Native Hawaiian/Other Pacific Islander Patients3 0.19% 0.00% 0.17%
Patients with More Than One Race3 2.02% 2.48% 0.82%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.48% 8.32% 9.24%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.87% 0.53% 0.21%
Unreported/Refused to Report Race and Ethnicity 4.42% 4.60% 4.58%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 38.60%
1 to 24 Hours 40.35%
More Than 24 Hours 17.54%
N/A 3.51%

Operations and Staff

Metrics Value
Percent of Health Centers Hosting Mobile Vans and/or Pop-Up, School-Based, or Family Vaccination Clinics 21.05%
Number of Mobile Van Sites or Pop-up, School-Based, or Family Vaccination Clinics 54
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 29.82%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 23
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 12,079

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 11
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 4,991

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 11
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 73.68%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 10.53%
White, Hispanic/Latino Patients 61.84%
Black/African American, Non-Hispanic/Latino Patients 3.95%
Black/African American, Hispanic/Latino Patients 1.32%
Asian Patients3 1.32%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 1.32%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.95%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.32%
Unreported/Refused to Report Race and Ethnicity 14.47%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 1.32%
Patients with Limited English Proficiency 15.79%
Children Under 18 Years of Age 5.26%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed: